Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEF2D
|
ENSG00000116604.13 | myocyte enhancer factor 2D |
MEF2A
|
ENSG00000068305.13 | myocyte enhancer factor 2A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_100109254_100109609 | MEF2A | 2743 | 0.325623 | 0.77 | 1.5e-02 | Click! |
chr15_100027235_100027578 | MEF2A | 10036 | 0.204350 | 0.77 | 1.5e-02 | Click! |
chr15_100014464_100014615 | MEF2A | 2831 | 0.289011 | 0.62 | 7.3e-02 | Click! |
chr15_100014188_100014339 | MEF2A | 3107 | 0.276311 | 0.59 | 9.4e-02 | Click! |
chr15_100017898_100018181 | MEF2A | 669 | 0.732407 | 0.54 | 1.3e-01 | Click! |
chr1_156447078_156447229 | MEF2D | 6069 | 0.130171 | 0.59 | 9.8e-02 | Click! |
chr1_156482148_156482299 | MEF2D | 11603 | 0.112247 | 0.58 | 1.0e-01 | Click! |
chr1_156466400_156466875 | MEF2D | 3892 | 0.146775 | 0.52 | 1.5e-01 | Click! |
chr1_156434373_156434524 | MEF2D | 18774 | 0.108483 | 0.51 | 1.6e-01 | Click! |
chr1_156434831_156434999 | MEF2D | 18307 | 0.109151 | 0.51 | 1.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_66050940_66051359 | 0.73 |
HMGA2 |
high mobility group AT-hook 2 |
166762 |
0.03 |
chr11_94661181_94661856 | 0.63 |
RP11-856F16.2 |
|
2832 |
0.29 |
chr6_85293592_85293821 | 0.61 |
RP11-132M7.3 |
|
105437 |
0.08 |
chr6_16903564_16904059 | 0.57 |
RP1-151F17.1 |
|
141668 |
0.05 |
chr18_67996235_67996386 | 0.55 |
RP11-41O4.1 |
Uncharacterized protein |
6365 |
0.22 |
chr5_77889982_77890133 | 0.53 |
LHFPL2 |
lipoma HMGIC fusion partner-like 2 |
45083 |
0.2 |
chr16_86775300_86775582 | 0.53 |
FOXL1 |
forkhead box L1 |
163326 |
0.03 |
chr14_56777353_56777504 | 0.52 |
TMEM260 |
transmembrane protein 260 |
177644 |
0.03 |
chr11_115488521_115488672 | 0.52 |
ENSG00000239153 |
. |
9307 |
0.31 |
chr16_11255917_11256068 | 0.51 |
CLEC16A |
C-type lectin domain family 16, member A |
36067 |
0.13 |
chr8_97803430_97803993 | 0.51 |
CPQ |
carboxypeptidase Q |
30243 |
0.25 |
chr22_29900076_29900399 | 0.50 |
NEFH |
neurofilament, heavy polypeptide |
24018 |
0.12 |
chr4_41180087_41180238 | 0.50 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
36313 |
0.15 |
chr9_101803098_101803249 | 0.50 |
TGFBR1 |
transforming growth factor, beta receptor 1 |
63147 |
0.11 |
chr21_43377285_43377631 | 0.49 |
C2CD2 |
C2 calcium-dependent domain containing 2 |
3459 |
0.24 |
chr1_55828154_55828305 | 0.49 |
ENSG00000199831 |
. |
14296 |
0.23 |
chr16_46782782_46782933 | 0.48 |
MYLK3 |
myosin light chain kinase 3 |
636 |
0.74 |
chr17_1700234_1700385 | 0.47 |
SMYD4 |
SET and MYND domain containing 4 |
3790 |
0.15 |
chr12_15842783_15842934 | 0.47 |
ENSG00000200105 |
. |
18114 |
0.22 |
chr12_27704088_27704418 | 0.47 |
PPFIBP1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
13197 |
0.23 |
chr1_110121167_110121450 | 0.46 |
ENSG00000206832 |
. |
12954 |
0.08 |
chr16_48478901_48479413 | 0.46 |
RP11-44I10.6 |
|
3152 |
0.22 |
chr17_74954230_74954498 | 0.45 |
ENSG00000267568 |
. |
10815 |
0.22 |
chr1_168467710_168467921 | 0.45 |
XCL2 |
chemokine (C motif) ligand 2 |
45420 |
0.16 |
chr12_6335494_6335645 | 0.44 |
ENSG00000202318 |
. |
8052 |
0.18 |
chr2_178332517_178332770 | 0.43 |
AGPS |
alkylglycerone phosphate synthase |
75147 |
0.07 |
chr5_148796784_148796935 | 0.43 |
ENSG00000208035 |
. |
11622 |
0.13 |
chr2_218766852_218767096 | 0.42 |
TNS1 |
tensin 1 |
242 |
0.95 |
chr16_73200279_73201088 | 0.42 |
C16orf47 |
chromosome 16 open reading frame 47 |
22337 |
0.26 |
chr11_124595331_124595482 | 0.42 |
NRGN |
neurogranin (protein kinase C substrate, RC3) |
14336 |
0.1 |
chr2_204553524_204553955 | 0.41 |
CD28 |
CD28 molecule |
17459 |
0.24 |
chr2_151519523_151519674 | 0.41 |
RND3 |
Rho family GTPase 3 |
124073 |
0.06 |
chr3_149050046_149050197 | 0.41 |
TM4SF18 |
transmembrane 4 L six family member 18 |
1148 |
0.5 |
chr12_66269655_66269806 | 0.41 |
RP11-366L20.2 |
Uncharacterized protein |
5628 |
0.2 |
chr1_68056079_68056230 | 0.41 |
ENSG00000207504 |
. |
49344 |
0.14 |
chr22_51016890_51017529 | 0.41 |
CPT1B |
carnitine palmitoyltransferase 1B (muscle) |
113 |
0.91 |
chr10_79150619_79150770 | 0.40 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
13048 |
0.23 |
chr16_75086975_75087126 | 0.40 |
ZNRF1 |
zinc and ring finger 1, E3 ubiquitin protein ligase |
50855 |
0.11 |
chr1_68638974_68639247 | 0.39 |
ENSG00000221203 |
. |
10183 |
0.22 |
chr7_75340828_75341228 | 0.39 |
HIP1 |
huntingtin interacting protein 1 |
27231 |
0.18 |
chr14_105721504_105721672 | 0.39 |
BRF1 |
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit |
5847 |
0.17 |
chr2_216363831_216363982 | 0.39 |
AC012462.1 |
|
62930 |
0.13 |
chr2_43135820_43135971 | 0.39 |
HAAO |
3-hydroxyanthranilate 3,4-dioxygenase |
116163 |
0.06 |
chr21_17584166_17584317 | 0.39 |
ENSG00000201025 |
. |
72848 |
0.13 |
chr15_25916381_25916532 | 0.39 |
ATP10A |
ATPase, class V, type 10A |
23516 |
0.19 |
chr2_220299434_220299585 | 0.39 |
SPEG |
SPEG complex locus |
59 |
0.95 |
chr2_158697443_158697594 | 0.39 |
ACVR1 |
activin A receptor, type I |
2679 |
0.28 |
chr11_123992842_123992993 | 0.39 |
VWA5A |
von Willebrand factor A domain containing 5A |
6760 |
0.19 |
chr8_17547050_17547201 | 0.39 |
ENSG00000265520 |
. |
7959 |
0.17 |
chr10_29611883_29612034 | 0.39 |
LYZL1 |
lysozyme-like 1 |
33968 |
0.21 |
chr2_30589074_30589411 | 0.39 |
ENSG00000221377 |
. |
66072 |
0.12 |
chr6_106589541_106589692 | 0.38 |
RP1-134E15.3 |
|
41601 |
0.16 |
chr7_19064312_19064463 | 0.38 |
AC003986.6 |
|
87710 |
0.08 |
chr17_73869045_73869430 | 0.38 |
TRIM47 |
tripartite motif containing 47 |
1736 |
0.17 |
chr2_193011657_193011808 | 0.38 |
TMEFF2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
47518 |
0.19 |
chr9_738221_738372 | 0.38 |
KANK1 |
KN motif and ankyrin repeat domains 1 |
5680 |
0.27 |
chr10_14778717_14778868 | 0.38 |
FAM107B |
family with sequence similarity 107, member B |
38104 |
0.16 |
chr18_55957694_55957845 | 0.37 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
32783 |
0.18 |
chr12_108292570_108292721 | 0.37 |
ENSG00000263632 |
. |
99148 |
0.07 |
chr3_25615486_25615637 | 0.37 |
ENSG00000272166 |
. |
18464 |
0.22 |
chr6_135045861_135046160 | 0.37 |
ALDH8A1 |
aldehyde dehydrogenase 8 family, member A1 |
204289 |
0.02 |
chr12_11932326_11932519 | 0.36 |
ETV6 |
ets variant 6 |
26987 |
0.25 |
chr4_86747445_86747851 | 0.36 |
ARHGAP24 |
Rho GTPase activating protein 24 |
1250 |
0.59 |
chr7_112124918_112125112 | 0.36 |
LSMEM1 |
leucine-rich single-pass membrane protein 1 |
3969 |
0.27 |
chr1_9473459_9474229 | 0.36 |
ENSG00000252956 |
. |
23993 |
0.2 |
chr9_84224859_84225018 | 0.36 |
TLE1 |
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
3499 |
0.36 |
chr6_106511937_106512088 | 0.36 |
PRDM1 |
PR domain containing 1, with ZNF domain |
22183 |
0.22 |
chr6_11211661_11211957 | 0.36 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
21082 |
0.2 |
chr20_43201295_43201704 | 0.36 |
PKIG |
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
9691 |
0.16 |
chr17_42247977_42248128 | 0.36 |
ASB16 |
ankyrin repeat and SOCS box containing 16 |
22 |
0.94 |
chr1_68212224_68212375 | 0.35 |
ENSG00000238778 |
. |
26037 |
0.19 |
chr12_107235247_107235617 | 0.35 |
RP11-144F15.1 |
Uncharacterized protein |
66736 |
0.1 |
chr12_31738710_31738861 | 0.34 |
DENND5B-AS1 |
DENND5B antisense RNA 1 |
4072 |
0.18 |
chr4_186842803_186842954 | 0.34 |
ENSG00000239034 |
. |
24359 |
0.19 |
chr2_159522500_159522651 | 0.34 |
AC005042.4 |
|
68755 |
0.11 |
chr5_36692406_36692557 | 0.34 |
CTD-2353F22.1 |
|
32794 |
0.22 |
chr9_112871990_112872141 | 0.34 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
15716 |
0.27 |
chr1_184476924_184477075 | 0.34 |
GS1-115G20.1 |
|
99528 |
0.07 |
chr20_47299343_47299823 | 0.34 |
ENSG00000251876 |
. |
56402 |
0.16 |
chr5_170922531_170922682 | 0.33 |
FGF18 |
fibroblast growth factor 18 |
75946 |
0.09 |
chr6_108724802_108724953 | 0.33 |
ENSG00000200799 |
. |
11600 |
0.25 |
chr19_11314159_11314310 | 0.33 |
CTC-510F12.2 |
|
70 |
0.94 |
chr3_45593577_45593808 | 0.33 |
ENSG00000251927 |
. |
40055 |
0.14 |
chr7_121012833_121012984 | 0.33 |
FAM3C |
family with sequence similarity 3, member C |
23454 |
0.22 |
chr2_173258743_173259031 | 0.33 |
ITGA6 |
integrin, alpha 6 |
33195 |
0.16 |
chr5_14210766_14211222 | 0.32 |
TRIO |
trio Rho guanine nucleotide exchange factor |
27087 |
0.27 |
chr11_95293251_95293402 | 0.32 |
ENSG00000201204 |
. |
86788 |
0.1 |
chr2_28556445_28556596 | 0.31 |
AC093690.1 |
|
23194 |
0.18 |
chr2_65138467_65138618 | 0.31 |
ENSG00000238696 |
. |
2722 |
0.24 |
chr5_167831336_167831487 | 0.31 |
WWC1 |
WW and C2 domain containing 1 |
1873 |
0.44 |
chr3_48597793_48598316 | 0.31 |
PFKFB4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
508 |
0.63 |
chr17_27946401_27946552 | 0.31 |
CORO6 |
coronin 6 |
1341 |
0.21 |
chr5_95482244_95482395 | 0.31 |
ENSG00000206997 |
. |
63612 |
0.12 |
chr10_12447179_12447330 | 0.31 |
ENSG00000252438 |
. |
10673 |
0.2 |
chr11_131926212_131926363 | 0.30 |
RP11-697E14.2 |
|
71732 |
0.13 |
chr3_185499420_185499571 | 0.30 |
ENSG00000265470 |
. |
13803 |
0.21 |
chr11_27487003_27487154 | 0.30 |
RP11-159H22.2 |
|
6198 |
0.18 |
chr22_27714638_27714789 | 0.30 |
ENSG00000200443 |
. |
282863 |
0.01 |
chr12_12032698_12032849 | 0.30 |
ETV6 |
ets variant 6 |
6098 |
0.32 |
chr7_129665295_129665446 | 0.30 |
ENSG00000201109 |
. |
1747 |
0.26 |
chr8_8458649_8458942 | 0.30 |
ENSG00000263616 |
. |
18630 |
0.21 |
chr4_186629734_186630027 | 0.30 |
ENSG00000207497 |
. |
1241 |
0.48 |
chr11_2404349_2404515 | 0.30 |
CD81 |
CD81 molecule |
742 |
0.5 |
chr5_173382092_173382267 | 0.30 |
C5orf47 |
chromosome 5 open reading frame 47 |
33983 |
0.18 |
chr11_96612522_96612673 | 0.29 |
ENSG00000200411 |
. |
404741 |
0.01 |
chr11_69264083_69264234 | 0.29 |
CCND1 |
cyclin D1 |
191697 |
0.03 |
chr11_3191381_3191561 | 0.29 |
OSBPL5 |
oxysterol binding protein-like 5 |
4471 |
0.17 |
chr6_72253421_72253572 | 0.29 |
ENSG00000212099 |
. |
4817 |
0.27 |
chr15_67816844_67817150 | 0.29 |
C15orf61 |
chromosome 15 open reading frame 61 |
2964 |
0.29 |
chr20_32978878_32979235 | 0.29 |
ENSG00000201498 |
. |
6985 |
0.16 |
chr12_49638204_49638355 | 0.29 |
TUBA1C |
tubulin, alpha 1c |
16570 |
0.11 |
chr13_75470100_75470251 | 0.29 |
ENSG00000206812 |
. |
213549 |
0.02 |
chr6_73470213_73470364 | 0.29 |
KCNQ5-IT1 |
KCNQ5 intronic transcript 1 (non-protein coding) |
130065 |
0.05 |
chr8_8730365_8730844 | 0.29 |
MFHAS1 |
malignant fibrous histiocytoma amplified sequence 1 |
20551 |
0.19 |
chr2_74995599_74995750 | 0.29 |
HK2 |
hexokinase 2 |
65434 |
0.1 |
chr3_177053679_177054041 | 0.29 |
TBL1XR1 |
transducin (beta)-like 1 X-linked receptor 1 |
138599 |
0.05 |
chr5_77149047_77149316 | 0.29 |
TBCA |
tubulin folding cofactor A |
15423 |
0.29 |
chr7_18545725_18546026 | 0.28 |
HDAC9 |
histone deacetylase 9 |
3021 |
0.37 |
chr4_71503415_71503566 | 0.28 |
ENAM |
enamelin |
9029 |
0.14 |
chr1_17945445_17945596 | 0.28 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
671 |
0.8 |
chr8_131307946_131308498 | 0.28 |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
44961 |
0.19 |
chr3_107938086_107938657 | 0.28 |
IFT57 |
intraflagellar transport 57 homolog (Chlamydomonas) |
2851 |
0.36 |
chr11_9350558_9350709 | 0.28 |
TMEM41B |
transmembrane protein 41B |
14306 |
0.18 |
chr20_50150448_50150603 | 0.28 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
8733 |
0.28 |
chr6_45486037_45486188 | 0.28 |
RUNX2 |
runt-related transcription factor 2 |
95890 |
0.08 |
chr9_83650488_83650760 | 0.28 |
ENSG00000221581 |
. |
301380 |
0.01 |
chr16_88448984_88449499 | 0.28 |
ZNF469 |
zinc finger protein 469 |
44638 |
0.14 |
chr20_23132592_23133523 | 0.28 |
ENSG00000201527 |
. |
8551 |
0.22 |
chr6_82660862_82661141 | 0.28 |
ENSG00000206886 |
. |
187260 |
0.03 |
chr6_140075001_140075152 | 0.28 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
379319 |
0.01 |
chr1_85224442_85225362 | 0.28 |
ENSG00000251899 |
. |
33980 |
0.18 |
chr7_50813178_50813329 | 0.28 |
GRB10 |
growth factor receptor-bound protein 10 |
10503 |
0.29 |
chr1_23428113_23428264 | 0.28 |
LUZP1 |
leucine zipper protein 1 |
7435 |
0.14 |
chr1_84945799_84946552 | 0.27 |
RPF1 |
ribosome production factor 1 homolog (S. cerevisiae) |
1225 |
0.46 |
chr11_128270550_128270701 | 0.27 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
104664 |
0.07 |
chr10_91405210_91405876 | 0.27 |
PANK1 |
pantothenate kinase 1 |
328 |
0.49 |
chr13_91415783_91415934 | 0.27 |
ENSG00000251753 |
. |
18265 |
0.31 |
chr14_35885344_35885586 | 0.27 |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
11513 |
0.26 |
chr1_52421500_52421651 | 0.27 |
ENSG00000200839 |
. |
17507 |
0.13 |
chr5_79542311_79543080 | 0.27 |
ENSG00000239159 |
. |
7287 |
0.19 |
chr2_202819063_202819214 | 0.27 |
ENSG00000221489 |
. |
1079 |
0.52 |
chr9_93954794_93955117 | 0.27 |
AUH |
AU RNA binding protein/enoyl-CoA hydratase |
169222 |
0.04 |
chr5_159306421_159306671 | 0.27 |
ADRA1B |
adrenoceptor alpha 1B |
37244 |
0.2 |
chr14_75828613_75828919 | 0.26 |
RP11-293M10.6 |
|
65627 |
0.09 |
chr3_17221418_17221569 | 0.26 |
ENSG00000252976 |
. |
44279 |
0.19 |
chr5_81460698_81461288 | 0.26 |
ENSG00000265684 |
. |
86747 |
0.08 |
chr6_140204099_140204250 | 0.26 |
ENSG00000252107 |
. |
275657 |
0.02 |
chr8_16613343_16613494 | 0.26 |
ENSG00000264092 |
. |
107587 |
0.07 |
chr9_5518413_5518594 | 0.26 |
PDCD1LG2 |
programmed cell death 1 ligand 2 |
7933 |
0.25 |
chr1_112289193_112289344 | 0.26 |
FAM212B-AS1 |
FAM212B antisense RNA 1 |
6793 |
0.17 |
chr4_157866649_157866809 | 0.26 |
PDGFC |
platelet derived growth factor C |
25326 |
0.2 |
chr7_129630529_129630680 | 0.26 |
ENSG00000263557 |
. |
5017 |
0.14 |
chr13_49672637_49672967 | 0.26 |
ENSG00000199788 |
. |
3275 |
0.28 |
chr2_218715975_218716307 | 0.26 |
TNS1 |
tensin 1 |
9258 |
0.27 |
chr10_98595394_98596081 | 0.26 |
LCOR |
ligand dependent nuclear receptor corepressor |
3000 |
0.26 |
chr12_89340554_89340705 | 0.26 |
ENSG00000238302 |
. |
335433 |
0.01 |
chr4_77491334_77491539 | 0.26 |
ENSG00000263445 |
. |
3285 |
0.21 |
chr20_50179743_50180109 | 0.26 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
556 |
0.85 |
chr2_189734866_189735017 | 0.26 |
AC079613.1 |
|
30770 |
0.2 |
chr13_51252402_51252553 | 0.26 |
DLEU7-AS1 |
DLEU7 antisense RNA 1 |
129515 |
0.05 |
chr7_55200144_55200295 | 0.26 |
EGFR |
epidermal growth factor receptor |
22679 |
0.24 |
chr12_32286981_32287354 | 0.26 |
RP11-843B15.2 |
|
26705 |
0.2 |
chr4_112855406_112855557 | 0.26 |
C4orf32 |
chromosome 4 open reading frame 32 |
211072 |
0.02 |
chr1_61299199_61299350 | 0.25 |
NFIA |
nuclear factor I/A |
31657 |
0.24 |
chr5_54776704_54777172 | 0.25 |
ENSG00000265135 |
. |
27816 |
0.18 |
chr8_133028834_133028985 | 0.25 |
OC90 |
otoconin 90 |
42718 |
0.18 |
chr12_110579233_110579384 | 0.25 |
IFT81 |
intraflagellar transport 81 homolog (Chlamydomonas) |
17111 |
0.22 |
chr13_111050298_111050449 | 0.25 |
ENSG00000238629 |
. |
16179 |
0.22 |
chr7_6291353_6291504 | 0.25 |
CYTH3 |
cytohesin 3 |
20847 |
0.16 |
chr7_151191145_151191634 | 0.25 |
RHEB |
Ras homolog enriched in brain |
23766 |
0.13 |
chr1_168605918_168606128 | 0.25 |
XCL1 |
chemokine (C motif) ligand 1 |
60312 |
0.13 |
chr6_25179466_25179765 | 0.25 |
ENSG00000222373 |
. |
13026 |
0.19 |
chr22_47544990_47545141 | 0.25 |
ENSG00000221672 |
. |
301262 |
0.01 |
chr9_79088043_79088199 | 0.25 |
GCNT1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
13975 |
0.26 |
chr6_116732049_116732623 | 0.25 |
DSE |
dermatan sulfate epimerase |
40226 |
0.11 |
chr13_21635893_21636207 | 0.25 |
LATS2 |
large tumor suppressor kinase 2 |
364 |
0.85 |
chr8_120566171_120566430 | 0.25 |
ENPP2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
38948 |
0.19 |
chr1_61853531_61853682 | 0.25 |
NFIA |
nuclear factor I/A |
16142 |
0.29 |
chr4_57275760_57275911 | 0.25 |
AC068620.1 |
Uncharacterized protein |
847 |
0.53 |
chr5_115789878_115790274 | 0.25 |
CTB-118N6.3 |
|
4650 |
0.26 |
chr9_95243384_95243848 | 0.25 |
ASPN |
asporin |
1172 |
0.49 |
chr10_3570543_3570694 | 0.25 |
RP11-184A2.3 |
|
222641 |
0.02 |
chr19_36715300_36715460 | 0.25 |
ZNF146 |
zinc finger protein 146 |
9345 |
0.12 |
chr5_133846467_133846815 | 0.25 |
ENSG00000240250 |
. |
6860 |
0.16 |
chr10_33260832_33260993 | 0.25 |
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
8701 |
0.27 |
chr12_13062950_13063285 | 0.25 |
GPRC5A |
G protein-coupled receptor, family C, group 5, member A |
1114 |
0.4 |
chr7_12624091_12624305 | 0.25 |
SCIN |
scinderin |
4355 |
0.26 |
chr1_206866532_206866832 | 0.24 |
MAPKAPK2 |
mitogen-activated protein kinase-activated protein kinase 2 |
8300 |
0.15 |
chr1_77862267_77862418 | 0.24 |
ENSG00000221664 |
. |
5129 |
0.23 |
chr15_25915798_25916253 | 0.24 |
ATP10A |
ATPase, class V, type 10A |
23947 |
0.19 |
chr3_16948269_16948754 | 0.24 |
PLCL2 |
phospholipase C-like 2 |
22059 |
0.21 |
chr10_44162371_44162574 | 0.24 |
ZNF32 |
zinc finger protein 32 |
18168 |
0.16 |
chr17_36577454_36577813 | 0.24 |
ARHGAP23 |
Rho GTPase activating protein 23 |
7029 |
0.16 |
chr17_41327708_41328475 | 0.24 |
NBR1 |
neighbor of BRCA1 gene 1 |
4831 |
0.16 |
chr10_80861964_80862203 | 0.24 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
33291 |
0.19 |
chr1_201729154_201729305 | 0.24 |
NAV1 |
neuron navigator 1 |
20233 |
0.11 |
chr2_155312519_155312670 | 0.24 |
AC009227.2 |
|
1356 |
0.52 |
chr9_116355859_116356115 | 0.24 |
RGS3 |
regulator of G-protein signaling 3 |
221 |
0.94 |
chr12_42841401_42841552 | 0.24 |
ENSG00000207142 |
. |
7046 |
0.16 |
chr3_189766577_189766728 | 0.24 |
ENSG00000265045 |
. |
65071 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.2 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.4 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.2 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.0 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.0 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0031223 | auditory behavior(GO:0031223) |
0.0 | 0.0 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.0 | 0.1 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.0 | 0.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0009180 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.0 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:1903224 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.0 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.0 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
0.0 | 0.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.1 | GO:0010658 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.0 | GO:1903670 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.0 | 0.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.0 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.2 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.0 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.1 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.0 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.1 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.0 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.0 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.1 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
0.0 | 0.0 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.0 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.0 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.1 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.0 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.0 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) |
0.0 | 0.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.2 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.2 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.3 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.2 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0044620 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.0 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |